tiprankstipranks
Thiogenesis Therapeutics Corp (TSE:TTI)
:TTI
Canadian Market

Thiogenesis Therapeutics Corp (TTI) Income Statement

Compare
1 Followers

Thiogenesis Therapeutics Corp Income Statement

Last quarter (Q3 2024), Thiogenesis Therapeutics Corp's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Thiogenesis Therapeutics Corp's net income was $-656.86K. See Thiogenesis Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Feb 22Feb 21Dec 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -5.06M$ -3.92M$ -224.43K$ -92.65K$ -473.55K
Operating Income
$ -5.21M$ -4.02M$ -224.68K$ -92.65K$ -473.39K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -5.06M$ -3.92M$ -224.46K$ -92.68K$ -476.30K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Thiogenesis Therapeutics Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis